Evidence map›Paper›PMID 33730092›Full record

ArticlePLoS pathogens2021

A heterochromatin inducing protein differentially recognizes self versus foreign genomes.

Eric M Burton, Ibukun A Akinyemi, Tiffany R Frey, Huanzhou Xu, Xiaofan Li, Lai Jing Su, Jizu Zhi, Michael T McIntosh, Sumita Bhaduri-McIntosh

Abstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Chromatin Control of EBV Infection and Latency.Current topics in microbiology and immunology · 2025
    Article
  3. Article
  4. Article
  5. KAP1 in antiviral immunity: dual roles in viral silencing and immune regulation.Frontiers in cellular and infection microbiology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Epigenetic control of the Epstein-Barr lifecycle.Current opinion in virology · 2022
    Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eric M BurtonDept. of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.ORCID 0000-0002-2432-2288
Ibukun A AkinyemiChild Health Research Institute, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America.
Tiffany R FreyChild Health Research Institute, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0002-4247-6715
Huanzhou XuDivision of Infectious Disease, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America.
Xiaofan LiDivision of Infectious Disease, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America.
Lai Jing SuChild Health Research Institute, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0003-1620-2881
Jizu ZhiDept of Pathology, Stony Brook University, Stony Brook, New York, United States of America.ORCID 0000-0002-7969-8143
Michael T McIntoshChild Health Research Institute, Depts. of Pediatrics and of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Sumita Bhaduri-McIntoshDivision of Infectious Disease, Depts. of Pediatrics and of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0003-2946-9497

Funding

MOLECULAR AND CELL BIOLOGY OF INFECTIOUS DISEASEST32AI007539 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI KONOPKA, JAMES B · 1998 to 2023
$3.6M
Host determinants of Epstein-Barr virus lytic cycle activationR01AI113134 · NIAID · UNIVERSITY OF FLORIDA · PI BHADURI-MCINTOSH, SUMITA · 2014 to 2018
$1.9M
sxRNA-based Antiviral Approach targeting Epstein-Barr virusR41AI115834 · NIAID · HOCUSLOCUS, INC. · PI BHADURI-MCINTOSH, SUMITA · 2015 to 2015
$225k
NIAID NIH HHS R01 AI113134NIAID NIH HHS R41 AI115834NIAID NIH HHS T32 AI007539
6 · The paper itself

Abstract

Krüppel-associated box-domain zinc finger protein (KRAB-ZFP) transcriptional repressors recruit TRIM28/KAP1 to heterochromatinize the mammalian genome while also guarding the host by silencing invading foreign genomes. However, how a KRAB-ZFP recognizes target sequences in the natural context of its own or foreign genomes is unclear. Our studies on B-lymphocytes permanently harboring the cancer-causing Epstein-Barr virus (EBV) have shown that SZF1, a KRAB-ZFP, binds to several lytic/replicative phase genes to silence them, thereby promoting the latent/quiescent phase of the virus. As a result, unless SZF1 and its binding partners are displaced from target regions on the viral genome, EBV remains dormant, i.e. refractory to lytic phase-inducing triggers. As SZF1 also heterochromatinizes the cellular genome, we performed in situ footprint mapping on both viral and host genomes in physically separated B-lymphocytes bearing latent or replicative/active EBV genomes. By analyzing footprints, we learned that SZF1 recognizes the host genome through a repeat sequence-bearing motif near centromeres. Remarkably, SZF1 does not use this motif to recognize the EBV genome. Instead, it uses distinct binding sites that lack obvious similarities to each other or the above motif, to silence the viral genome. Virus mutagenesis studies show that these distinct binding sites are not only key to maintaining the established latent phase but also silencing the lytic phase in newly-infected cells, thus enabling the virus to establish latency and transform cells. Notably, these binding sites on the viral genome, when also present on the human genome, are not used by SZF1 to silence host genes during latency. This differential approach towards target site recognition may reflect a strategy by which the host silences and regulates genomes of persistent invaders without jeopardizing its own homeostasis.

Indexed as

B-LymphocytesEpstein-Barr Virus InfectionsGene SilencingHerpesvirus 4, HumanHeterochromatinHumansRepressor ProteinsVirus LatencyHeterochromatinRepressor ProteinsZNF589 protein, human

Identifiers

PMID33730092
PMCPMC8007004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.